Michael Mullan is a biomedical researcher of the beta amyloid protein and its relation to Alzheimer’s disease. Mike Mullan's Alzheimer research is well known among Biomedical Community. Dr. Mullan's Alzheimer research work resulted in identifying the most widely known Swiss Mutation that is present in familial form. Transgenic Animal for Alzheimer Disease uses Swedish Mutation. Dr. Michael Mullan is currently the director of the Roskamp Institute in Sarasota, Florida. Under the guidance of Dr. Michael Mullan's the institute is carrying out cutting edge research in Alzheimer's, Traumatic Brain Research, Gulf War Illness and other neuropsychiatric disorder. The Roskamp Institute is a non-profit research organization that is devoted to understanding causes of and finding cures for neuropsychiatric and neurodegenerative disorders. Based in Sarasota, Florida, the Institute utilizes a broad range of scientific approaches to understanding the causes of and potential therapies for these disorders with an emphasis on Alzheimer's disease.Headed by Dr. Mike Mullan and Dr. Fiona Crawford, the institute employs experienced and interdisciplinary scientists and technicians and houses state-of-the-art research labs and equipment to conduct scientific research. The quality of research performed at the institute reflects its motto: "Better science. Real discovery." Source: South East High

The Mission of The Roskamp Institute is to conduct scientific research to discover safe and effective new drug therapies to successfully treat diseases of the mind and to promote healthy aging.



_

_ Walking into the Memory Disorder Clinic at the Roskamp Institute one might ask “Why work with Alzheimer’s patients and their families?”  The answers are manyfold.  One of the most rewarding aspects of working with Alzheimer’s patients is that they are most commonly our oldest citizens who have 60, 70 or 80 years of life experience behind them  many of them have served their country in one form or another  - frequently in the military but often times in businesses working for others or their own companies.  Many of those serving in the armed forces have captivating stories.  One visitor to the clinic had parachuted into three war zones Normandy, the “boot” of Italy, and Germany.  Remembering this tale this gentleman was most afraid of being shot by the Russians!  Of course being able to recall these old memories is not unusual for Alzheimer disease suffers.  In fact the tendency to reminisce sometimes becomes a prominent feature of the disorder.  Most caregivers are initially concerned by another aspect of the disorder namely the forgetfulness for recently acquired or presented information.  Such things as recent visits recent phone calls or recent conversations and events may not be remembered either in part or in full.  This distressing symptom interferes with social activities and is a progressive aspect of the disease.  Therefore one of the most rewarding aspect of working with Alzheimer’s sufferers and their families is being able to convey to them the several treatment options that are available.  This includes, as well as those drugs approved by the FDA, new and experimental treatments including those that are being developed by the Roskamp Institute itself. 

All in all there is much to recommend a profession working and caring for Alzheimer’s patients. Our elderly are frequently amongst our most valued citizens who have contributed to the prosperity and safety of subsequent generations.  Continuing to work for their immediate care and finding new treatments to improve their long term prognosis are the premier interests of the Roskamp Institute’s researchers, physicians and clinicians.